S100A7 and neoplasm: S100A7 expression was associated with tumor heterogeneity (TMB, MATH, microsatellite instability, neoantigen, purity, ploidy, homologous recombination deficiency (HRD), and loss of heterozygosity (LOH) scores; Figure 10A).